Citrulline

Bizz Energy's SuperTurk Blend is Revolutionizing Clean Energy Drinks

Retrieved on: 
Tuesday, November 21, 2023
Amino acid, Athlete, Biotin, Student, Jacono, Citrulline, Carnitine, Code, Dietary supplement, Soft drink, Turkesterone, Creatine, Niacin

FORT LAUDERDALE, Fla., Nov. 21, 2023 /PRNewswire/ -- Bodybuilders, athletes, and fitness enthusiasts from all walks of life are always in search of the best way to reach their peak performance. Thrill seekers, go-getters, and students are also always on the lookout for a clean, effective pick-me-up to help optimize their activities. From physical performance to mental focus, people from all walks of life are constantly in search of effective energy solutions.

Key Points: 
  • From physical performance to mental focus, people from all walks of life are constantly in search of effective energy solutions.
  • Bizz Energy is answering this universal need with a clean, sugar-free, zero-calorie formula that is free of harmful chemicals, additives, and aspartame.
  • The innovative energy drink contains ingredients that enhance energy, endurance, and focus, including the unique addition of Turkesterone.
  • "Bizz Energy isn't just another take on your run-of-the-mill energy drink," Jacono declares.

ZOA Energy Launches Revolutionary Five-in-One Pre-Workout Supplement with Setria® Glutathione

Retrieved on: 
Tuesday, November 7, 2023
Research, Dwyane Wade, Sport, Food, Creatine, RD, Certification, Dwayne Johnson, MBA, Nitric oxide, Athlete, Interview, Β-Alanine, Trust, Rock, Disease, Tyrosine, Glutathione, NO, Alanine, Ginkgo, Safety, Citrulline, Electrolyte, Food and Drug Administration, Fatigue, Dietary supplement, ZOA, Amazon

NEW YORK, Nov. 7, 2023 /PRNewswire-PRWeb/ -- The newly launched ZOA+ Powder pre-workout supplement has discerning athletes running to hit the gym to maximize their workouts. ZOA+ includes premium ingredients like Setria®, a clinically studied and patented form of glutathione that helps to replenish the body's reserves*, in its five-in-one advanced formula with a powerful combination of Nitric Oxide (NO) alongside training support, natural caffeine, and electrolytes, while promoting focus for a peak performance workout.

Key Points: 
  • ZOA+ Powder is a natural addition to the growing list of products containing Kyowa Hakko's Setria® Glutathione.
  • Research suggests that Setria® Glutathione may support an increase in NO production when combined with L-Citrulline**, which is also contained in ZOA+.
  • Formulated by ZOA Energy Co-founder and Chief Innovation Officer, Dave Rienzi, ZOA+ Powder promises a superior fitness experience.
  • According to Rienzi, "This launch represents a remarkable stride for ZOA Energy, as we reshape the standards of excellence in the fitness industry and beyond."

CJ Food & Nutrition Tech and KAGED Announce Exciting Collaboration, Bringing Shared Values and Commitments Together

Retrieved on: 
Monday, September 25, 2023
Partnership, Nitric oxide, CJ, Fermentation, ELITE, Athlete, Citrulline, Health, Social media, Fatigue, Dietary supplement, Management

DOWNERS GROVE, Ill., Sept. 25, 2023 /PRNewswire/ -- CJ Food & Nutrition Tech (CJ FNT) and KAGED are excited to announce their collaboration, which marks CJ FNT's first AMINATURE® brand partnership.

Key Points: 
  • DOWNERS GROVE, Ill., Sept. 25, 2023 /PRNewswire/ -- CJ Food & Nutrition Tech (CJ FNT) and KAGED are excited to announce their collaboration, which marks CJ FNT's first AMINATURE® brand partnership.
  • Pre-KAGED ELITE contains CJ FNT's AMINATURE L-citrulline, a natural amino acid that is produced through microbial fermentation.
  • "We are thrilled to partner with KAGED on this groundbreaking initiative," said Steve Pak, Chief Marketing Officer of CJ FNT.
  • Both CJ FNT and KAGED will work together to prioritize the health, joy, and convenience of their discerning customers.

WWE® & C4® EXPAND PARTNERSHIP AND LAUNCH FIRST-EVER PRODUCT COLLABORATION

Retrieved on: 
Thursday, July 27, 2023
Universe, Rhea, Pomegranate, Superstar, SummerSlam, Partnership, Life, WWE, WWE Championship, Great Lakes Crossing Outlets, Ford Field, Β-Alanine, Great Lakes, Nitric oxide, WWE Superstars, Work, Caffeine, Seth Rollins, GNC, Athlete, Collection, Citrulline, Love, WWE Universal Championship, NYSE, Nightclub, Video game, WrestleMania, C4

STAMFORD, Conn., July 27, 2023 /PRNewswire/ -- WWE® (NYSE: WWE) and Nutrabolt, owner of the C4® brand, today announced an expansion to their multi-year partnership with the launch of their first-ever co-branded product collaboration: WWE-inspired flavors of C4 Ultimate Pre-Workout Powder and C4 Ultimate Energy Drink. The products will be available exclusively at GNC ahead of WWE SummerSlam® in Detroit on Saturday, August 5.

Key Points: 
  • The products will be available exclusively at GNC ahead of WWE SummerSlam® in Detroit on Saturday, August 5.
  • "C4 has been an outstanding partner and we are excited about the launch of our first collaborative retail activation and extending our sponsorship work together.
  • To celebrate the launch, C4 is debuting the "Not Safe For Work" creative campaign that explores the right (and wrong) ways to consume C4 Ultimate Energy.
  • The new C4 Ultimate x WWE products are available exclusively at GNC stores nationwide, online at GNC.com , and on cellucor.com .

WWE® & C4® Expand Partnership and Launch First-Ever Product Collaboration

Retrieved on: 
Thursday, July 27, 2023
Film & Motion Pictures, Sports, TV and Radio, Health, General Health, Wrestling, Food, Beverage, Entertainment, Vitamins, Supplements, Retail, Fitness & Nutrition, Universe, Rhea, Pomegranate, Superstar, SummerSlam, Partnership, Life, WWE, WWE Championship, Great Lakes Crossing Outlets, Ford Field, Β-Alanine, Great Lakes, Nitric oxide, WWE Superstars, Multimedia, Caffeine, LAUNCH, GNC, Athlete, Collection, Citrulline, Love, WWE Universal Championship, NYSE, Nightclub, Video game, WrestleMania, C4

WWE® (NYSE: WWE) and Nutrabolt, owner of the C4® brand, today announced an expansion to their multi-year partnership with the launch of their first-ever co-branded product collaboration: WWE-inspired flavors of C4 Ultimate Pre-Workout Powder and C4 Ultimate Energy Drink.

Key Points: 
  • WWE® (NYSE: WWE) and Nutrabolt, owner of the C4® brand, today announced an expansion to their multi-year partnership with the launch of their first-ever co-branded product collaboration: WWE-inspired flavors of C4 Ultimate Pre-Workout Powder and C4 Ultimate Energy Drink.
  • View the full release here: https://www.businesswire.com/news/home/20230727241018/en/
    WWE® & C4® EXPAND PARTNERSHIP AND LAUNCH FIRST-EVER PRODUCT COLLABORATION (Photo: Business Wire)
    Allowing consumers to unleash their ultimate undisputed performance, the C4 Ultimate Energy x WWE collection will consist of five special edition flavors and each product label will feature design inspiration drawn from WWE Championship titles.
  • “C4 has been an outstanding partner and we are excited about the launch of our first collaborative retail activation and extending our sponsorship work together.
  • The new C4 Ultimate x WWE products are available exclusively at GNC stores nationwide, online at GNC.com, and on cellucor.com.

JYM Supplement Science launches DragonBerry Pre JYM X at GNC

Retrieved on: 
Thursday, July 13, 2023
Science, Methylliberine, Wetsuit / Tiger Blood, Shock wave, Creatine, Citrulline, Fruit, GNC, JYM, Β-Alanine, Rest, Soft drink

WESTLAKE VILLAGE, Calif., July 13, 2023 /PRNewswire-PRWeb/ -- The newest flavor of the industry-leading Pre JYM X pre-workout – Dragonberry – is officially live at GNC locations nationwide, as well as GNC.com.

Key Points: 
  • Pre JYM X was introduced to the sports nutrition landscape in March 2022 following the unparalleled success of the original Pre JYM formula launched in the summer of 2013.
  • Dragonberry is the fourth flavor created for Pre JYM X, the first three (Shockwave, Rise N Grind, and Tiger's Blood) available since inception in 2013.
  • "This is one of my favorite flavors we've ever created in the JYM line," says Dr. Jim Stoppani, co-owner and formulator of JYM Supplement Science.
  • With Dragonberry Pre JYM X, Dr. Stoppani has once again outdone himself."

Six Star Pro Nutrition® Introduces New and Improved Pre-Workout Explosion 2.0 Formula

Retrieved on: 
Tuesday, June 6, 2023
Electrolyte, Taste, Β-Alanine, Weight loss, Caffeine, Associate, Athlete, Citrulline, Pink Lemonade, SIX, Dietary supplement, Sport

To support athletes with the pre-training fuel they need, Six Star Pro Nutrition® has reinvigorated its top-selling pre-workout formula to provide athletic excellence at family-friendly prices.

Key Points: 
  • To support athletes with the pre-training fuel they need, Six Star Pro Nutrition® has reinvigorated its top-selling pre-workout formula to provide athletic excellence at family-friendly prices.
  • SIX STAR® overhauled its entire flavor system for this next level pre-workout, resulting in an enhanced taste experience for consumers.
  • "Our new Pre-Workout Explosion 2.0 hits harder, tastes better, and has been reformulated for enhanced performance.
  • Not only does this new hybrid formula hit harder, it also tantalizes your taste buds like never before.

Wistar Scientists Discover Innate Tumor Suppression Mechanism

Retrieved on: 
Thursday, May 4, 2023
Online, Perelman School of Medicine at the University of Pennsylvania, Database, CRISPR, Human, Cell biology, Ashkenazi Jews, University, Molecule, Life, Fox Chase Cancer Center, University of Kansas, Culture, Neoplasm, Infection, St. Jude Children's Research Hospital, Cancer, American Association for Cancer Research, Biomedical Research, Mutation, Research, Immunotherapy, Ellen, PADI4, Citrulline, Patient, Wistar Institute, Risk, Machine learning, Engineering, Immune system, Ausländer, Paper, Mouse, Artificial intelligence, Gene, TCGA, NIH, African Americans, Genome, Vaccine, Pharmaceutical industry, Medical device, Wistar, Cancer Discovery (journal)

Now, in a recent study published in Cancer Discovery , a journal of the American Association for Cancer Research, researchers at The Wistar Institute have uncovered a key mechanism as to how p53 suppresses tumors.

Key Points: 
  • Now, in a recent study published in Cancer Discovery , a journal of the American Association for Cancer Research, researchers at The Wistar Institute have uncovered a key mechanism as to how p53 suppresses tumors.
  • Publication information: An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression, Cancer Discovery, 2023.
  • Wistar scientists are focused on solving some of the world’s most challenging and important problems in the field of cancer, infectious disease, and immunology.
  • Consistent with its legacy of leadership in biomedical research and a track record of life-saving contributions in immunology and cell biology, Wistar scientists’ early-stage discoveries shorten the path from bench to bedside.

EQS-News: Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders

Retrieved on: 
Thursday, May 4, 2023
Fatigue, Histology, Diarrhea, Gastrointestinal tract, Biotechnology, Clinical trial, Pharmacokinetics, Nutrient, Brain, Irritable bowel syndrome, Absorption, Inflammation, Improvement, Abdominal pain, Ulcerative colitis, Regeneration, ET, Patient, Citrulline, Nervous system, Immune system, Vitamin B12, Nausea, Bloating, Growth, Health, Conference, Safety, Conditional sentence, Malabsorption, Vaccine, Dietary supplement, Silviculture, Pharmaceutical industry, Medical imaging, Online shopping, Webcast, Coeliac disease, Short course immune induction therapy

Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders

Key Points: 
  • Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders
    The issuer is solely responsible for the content of this announcement.
  • The company believes that this data set provides initial clinical proof-of-concept for an entirely new therapeutic approach to gastrointestinal disorders by promoting regeneration of bowel architecture.
  • Decrease in villous height is a well-recognized measure of gluten-induced damage in celiac disease and a main reason for signs and symptoms of malabsorption.
  • Immunic will host a webcast today, May 4, 2023, at 8:00 am ET to discuss these results.

Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders

Retrieved on: 
Thursday, May 4, 2023
Fatigue, Histology, Diarrhea, Gastrointestinal tract, Clinical trial, Pharmacokinetics, Nutrient, Brain, Irritable bowel syndrome, Absorption, Inflammation, Improvement, Abdominal pain, Ulcerative colitis, Crohn's disease, Regeneration, ET, Patient, Citrulline, Nervous system, Immune system, Vitamin B12, Nausea, Bloating, Growth, Health, Coeliac disease, Conference, Safety, Conditional sentence, Malabsorption, Medical imaging, Silviculture, Pharmaceutical industry, Dietary supplement, Vaccine, Webcast, Short course immune induction therapy

NEW YORK, May 4, 2023 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced positive results from the part C portion of its phase 1 clinical trial of IMU-856 in patients with celiac disease. The company believes that this data set provides initial clinical proof-of-concept for an entirely new therapeutic approach to gastrointestinal disorders by promoting regeneration of bowel architecture.

Key Points: 
  • The company believes that this data set provides initial clinical proof-of-concept for an entirely new therapeutic approach to gastrointestinal disorders by promoting regeneration of bowel architecture.
  • Decrease in villous height is a well-recognized measure of gluten-induced damage in celiac disease and a main reason for signs and symptoms of malabsorption.
  • Immunic will host a webcast today, May 4, 2023, at 8:00 am ET to discuss these results.
  • Registrants will receive a confirmation email containing a link for online participation or a telephone number for dial in access.